| Literature DB >> 28342665 |
Ran Zhao1, Junfeng Sun2, Tianming Qi2, Wen Zhao2, Zongxi Han2, Xiaopu Yang3, Shengwang Liu4.
Abstract
The recombinant LaSota strain expressing a chimeric IBV S1 gene (rLaSota-S1) was constructed with the S1 gene of the LX4 type IBV ck/CH/LDL/091022. The expression of the S1 protein was detected by an indirect immunofluorescence assay and Western blotting. The rLaSota-S1 strain was slightly attenuated, and its growth dynamics were similar to that of the parental LaSota strain. Vaccination of specific pathogen-free chickens with the rLaSota-S1 strain induced NDV hemagglutination inhibition antibodies, and it protected chickens from challenge with virulent NDV. In addition, vaccination with the rLaSota-S1 strain induced IBV-specific IgG antibodies and cellular immunity; however, a single vaccination provided partial protection with reduced virus shedding. Better protection efficiency was observed after a booster vaccination, which resulted in higher antibody titers, significantly fewer disease symptoms, and reduced virus replication and shedding. Our results suggest that the rLaSota-S1 strain is a bivalent vaccine candidate against both NDV and IBV.Entities:
Keywords: Bivalent vaccine candidate; Infectious bronchitis virus; LX4 genotype; Newcastle disease virus; Recombinant LaSota strain
Mesh:
Substances:
Year: 2017 PMID: 28342665 DOI: 10.1016/j.vaccine.2017.03.045
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641